GST Pull--down Assay - GST or GST--tagged Tudor domain proteins were expressed in E. coli strain BL21 by induction of IPTG for 4 hours at 30°C. Total bacteria were solicited and the lysate was incubated with Glutathione Sepharose 4B (GE Healthcare) at 4°C overnight. The sepharose bound proteins were washed with PBS for 3 times and eluted with 25mM reduced glutathione. PRMT5 flox/flox MEFs were lysed with mild buffer and incubated with the recombinant GST or GST--SMN Tudor domain at 4°C overnight. Then sepharose were added and incubated for 1 hour. The beads were then pelleted and washed with PBS for 3 times and the bound proteins were eluted with SDS loading buffer and subjected to Western blotting for the detection of indicated proteins. Antibodies -PRMT1 antibody (a gift from Dr. Stephane Richard), pan--ADMA substrate antibody (collaboration with Cell Signaling Technologies), anti--LDH (Santa Cruz) and anti--Lamin A/C (Santa Cruz), LC3B, eIF2α and phosphorylated eIF2α (S51) antibodies (from Cell Signaling Technologies). Immunofluorescence Staining for hnRNP A1 -PRMT5 flox/flox MEFs were treated with or without 4--hydroxytamoxifen for 7 days and plated onto coverslips and cultured for 24 hours. Cells were washed, fixed with 4% paraformaldehyde for 10 min at room temperature, permeabilized with PBS containing 0.2% Triton and 0.8% FBS and washed three times with PBS. The cells were blocked with PBS containing 1% FBS for 1 hour, and anti--hnRNP A1 antibody was added to the coverslips and incubated for 2 hours. The cells were stained with Alexa Fluor 647--conjugated anti--mouse antibody followed by staining with 0.25μg/ml DAPI. Primers used for qPCR: Primers for both mouse and human: PRMT5: TCAAAGCAGCCATTCTCCCCAC (For.) and TGGTTGGTGCCTGTGATGATGAAC (Rev.) MEP50: AGACACTTATTGTCAGCAAG (For.) and AATCTGTGATGCTGGCTTG (Rev.) Primers for human only: CCND1: CTCCTGTGCTGCGAAGTGG (For.) and CTTCTGTTCCTCGCAGACCTCC (Rev.) MYC: AGCGACTCTGAGGAGGAACA (For.) and CCCTCTTGGCAGCAGGATAG (Rev.) 
HIF1a: ATCACCCTCTTCGTCGCTTC (For.) and ACTTATCTTTTTCTTGTCGTTCGC (Rev.) ESR1: ACAAGCGCCAGAGAGATGAT (For.) and AAGGTTGGCAGCTCTCATGT (Rev.) GAPDH: AGCCACATCGCTCAGACAC (For.) and GCCCAATACGACCAAATCC (Rev.) Primers for mouse only: CCND1: CCAACAACTTCCTCTCCTGCT (For.) and GACTCCAGAAGGGCTTCAATC (Rev.) MYC: TCTCCACTCACCAGCACAACTACG (For.) and ATCTGCTTCAGGACCCT (Rev.) HIF1a: GCGAGAACGAGAAGAAAAAGATGA (For.) and GCCGTCATCTGTTAGCACCA (Rev.) ESR1: CTTCAGTGCCAACAGCCT (For.) and GACAGTCTCTCTCGGCCAT (Rev.) GAPDH: CCCACTAACATCAAATGGGG (For.) and CCTTCCACAATGCCAAAGTT (Rev.)
A B Figure S1 : Methyla1on of hnRNP A1 by PRMT5 does not affect its subcellular localiza1on. PRMT5 flox/flox MEFs were treated with or without 2 μM tamoxifen for 8 days. A. Then half of the cells were fixed and stained with anK--hnRNP A1 anKbody followed by Alexa Fluor 647 conjugated anK--mouse secondary anKbody (red), and DAPI staining (blue). B. The other half were lysed with cytoplasmic/nuclear fracKonaKon kit, and subjected to Western bloVng for hnRNP A1. PRMT5 was also detected to control the knockout efficiency; LDH and Lamin A/C were for controlling fracKonaKon. 
